Clearance of Pneumocystis murina infection is not dependent on MyD88

Chiara Ripamonti1, Lisa R Bishop1, Jun Yang2

  • 1Critical Care Medicine Department, NIH Clinical Center, NIH, Building 10, Room 2C145, MSC 1662, Bethesda, MD 20892-1662, USA.

Insights

Myeloid differentiation factor 88 (MyD88) is not required for controlling Pneumocystis pneumonia. MyD88-deficient mice effectively cleared the infection and developed antibodies, similar to wild-type mice.

Area of Science:

  • Immunology
  • Microbiology
  • Infectious Diseases

Background:

  • Myeloid differentiation factor 88 (MyD88) is a crucial adaptor protein in Toll-like receptor (TLR) and IL-1 receptor signaling pathways.
  • Understanding the role of MyD88 in host defense against opportunistic pathogens like Pneumocystis is essential for developing targeted therapies.

Purpose of the Study:

  • To investigate the necessity of MyD88 signaling in controlling Pneumocystis infection in a murine model.
  • To determine if MyD88-deficient mice exhibit impaired immune responses or fungal clearance compared to wild-type controls.

Main Methods:

  • MyD88-deficient and wild-type mice were infected with Pneumocystis via exposure to infected donor mice.
  • Mice were monitored for up to 106 days post-infection.
  • Fungal clearance, antibody development, and gene expression levels were assessed.

Main Results:

  • MyD88-deficient mice successfully cleared Pneumocystis infection.
  • Anti-Pneumocystis antibody responses developed in MyD88-deficient mice with kinetics comparable to wild-type mice.
  • Gene expression analysis indicated similar immune responses between MyD88-deficient and wild-type mice.

Conclusions:

  • Myeloid differentiation factor 88 (MyD88) and its upstream signaling pathways are not essential for the control of Pneumocystis infection.
  • Host immune responses, including antibody production and fungal clearance, can proceed effectively independently of MyD88 signaling in this context.